Responses
Pharmacology and therapeutics
Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.